A 5285: Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

  
  STATE OF NEW YORK ________________________________________________________________________ 5285 2025-2026 Regular Sessions  IN ASSEMBLY February 12, 2025 ___________ Introduced by M. of A. REYES -- read once and referred to the Committee on Higher Education AN ACT to amend the education law and the public health law, in relation to prescription labels for mifepristone and misoprostol The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph b-1 of subdivision 1 of section 6807 of the 2 education law, as added by a chapter of the laws of 2025 amending the 3 education law relating to the labeling of mifepristone, misoprostol, and 4 their generic alternatives, as proposed in legislative bills numbers S. 5 36-A and A. 2145-A, is amended to read as follows: 6 b-1. Notwithstanding paragraph b of this section, the prescription 7 label for mifepristone[,] or misoprostol[, and their generic alterna- 8 tives] may include the name or address of the dispensing health care 9 practice instead of the name of the dispenser. 10 § 2. Subdivision 1-a of section 6810 of the education law, as added by 11 a chapter of the laws of 2025 amending the education law relating to the 12 labeling of mifepristone, misoprostol, and their generic alternatives, 13 as proposed in legislative bills numbers S. 36-A and A. 2145-A, is 14 amended to read as follows: 15 1-a. Notwithstanding subdivision one of this section, at the 16 prescriber's request, the prescription label for mifepristone[,] or 17 misoprostol[, and their generic alternatives may] shall include the name 18 or address of the prescribing health care practice instead of the name 19 of the prescriber. 20 § 3. The public health law is amended by adding a new section 280-d to 21 read as follows: 22 § 280-d. Patient notification of prescription label change. A health 23 care prescriber shall inform the patient if such prescriber has included 24 or has requested to include the name or address of the prescribing EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD09082-01-5 
 A. 5285 2 1 health care practice instead of the name of such prescriber on the 2 prescription label when prescribing mifepristone or misoprostol. 3 § 4. This act shall take effect on the same date and in the same 4 manner as a chapter of the laws of 2025 amending the education law 5 relating to the labeling of mifepristone, misoprostol, and their generic 6 alternatives, as proposed in legislative bills numbers S. 36-A and A. 7 2145-A, takes effect.